These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 7778214

  • 1. Indium-111-DTPA-octreotide scintigraphy modulation by treatment with unlabelled somatostatin analogue in small-cell lung cancer.
    Soresi E, Bombardieri E, Chiti A, Boffi R, Invernizzi G, Crippa F, Maffioli L.
    Tumori; 1995; 81(2):125-7. PubMed ID: 7778214
    [Abstract] [Full Text] [Related]

  • 2. 111In-DTPA-D-Phe-1-octreotide scintigraphy of small cell lung cancer.
    Bombardieri E, Chiti A, Crippa F, Seregni E, Cataldo I, Maffioli L, Soresi E.
    Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):104-7. PubMed ID: 9002763
    [Abstract] [Full Text] [Related]

  • 3. Clinical diagnostic application of 111In-DTPA-octreotide scintigraphy in small cell lung cancer.
    Vaccarili M, Lococo A, Fabiani F, Staffilano A.
    Tumori; 2000 Dec; 86(3):224-8. PubMed ID: 10939603
    [Abstract] [Full Text] [Related]

  • 4. Somatostatin receptor imaging of small cell lung cancer (SCLC) by means of 111In-DTPA octreotide scintigraphy.
    Bombardieri E, Crippa F, Cataldo I, Chiti A, Seregni E, Soresi E, Boffi R, Invernizzi G, Buraggi GL.
    Eur J Cancer; 1995 Dec; 31A(2):184-8. PubMed ID: 7718323
    [Abstract] [Full Text] [Related]

  • 5. 111In-octreotide scintigraphy in small cell lung cancer.
    Semprebene A, Ferraironi A, Franciotti G, Venturo I, Giunta S, Lopez M, Maini CL.
    Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):108-10. PubMed ID: 9002764
    [Abstract] [Full Text] [Related]

  • 6. Intensification of 111In-DTPA-octreotide scintigraphy by means of pretreatment with cold octreotide in small cell lung cancer.
    Soresi E, Invernizzi G, Boffi R, Possa M, Bombardieri E, Ciavarella GP, Liuzzi A.
    Lung Cancer; 1997 Jul; 17(2-3):231-8. PubMed ID: 9237158
    [Abstract] [Full Text] [Related]

  • 7. A new radiolabelled somatostatin analogue [111In-DTPA-D-Phe1]RC-160: preparation, biological activity, receptor scintigraphy in rats and comparison with [111In-DTPA-D-Phe1]octreotide.
    Breeman WA, Hofland LJ, van der Pluijm M, van Koetsveld PM, de Jong M, Setyono-Han B, Bakker WH, Kwekkeboom DJ, Visser TJ, Lamberts SW.
    Eur J Nucl Med; 1994 Apr; 21(4):328-35. PubMed ID: 7911760
    [Abstract] [Full Text] [Related]

  • 8. Somatostatin receptor imaging in small cell lung cancer.
    Berenger N, Moretti JL, Boaziz C, Vigneron N, Morere JF, Breau JL.
    Eur J Cancer; 1996 Jul; 32A(8):1429-31. PubMed ID: 8869110
    [Abstract] [Full Text] [Related]

  • 9. The value of octreotide scintigraphy in patients with lung cancer.
    Kwekkeboom DJ, Kho GS, Lamberts SW, Reubi JC, Laissue JA, Krenning EP.
    Eur J Nucl Med; 1994 Oct; 21(10):1106-13. PubMed ID: 7828621
    [Abstract] [Full Text] [Related]

  • 10. [111In-DTPA-D-Phe1]octreotide scintigraphy in patients with carcinoid tumours: the predictive value for somatostatin analogue treatment.
    Janson ET, Westlin JE, Eriksson B, Ahlström H, Nilsson S, Oberg K.
    Eur J Endocrinol; 1994 Dec; 131(6):577-81. PubMed ID: 7804439
    [Abstract] [Full Text] [Related]

  • 11. Somatostatin receptor scintigraphy of carcinoid tumours using the [111In-DTPA-D-Phe1]-octreotide.
    Westlin JE, Janson ET, Arnberg H, Ahlström H, Oberg K, Nilsson S.
    Acta Oncol; 1993 Dec; 32(7-8):783-6. PubMed ID: 8305227
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [111-indium DTPA octreotide scintigraphy in colorectal liver metastases].
    Seifert JK, Görges R, Bockisch A, Junginger T.
    Langenbecks Arch Chir; 1997 Dec; 382(6):332-6. PubMed ID: 9498205
    [Abstract] [Full Text] [Related]

  • 16. Somatostatin receptor scintigraphy in small-cell lung cancer: results of a multicenter study.
    Reisinger I, Bohuslavitzki KH, Brenner W, Braune S, Dittrich I, Geide A, Kettner B, Otto HJ, Schmidt S, Munz DL.
    J Nucl Med; 1998 Feb; 39(2):224-7. PubMed ID: 9476922
    [Abstract] [Full Text] [Related]

  • 17. 111In-labelled somatostatin analogues in a rat tumour model: somatostatin receptor status and effects of peptide receptor radionuclide therapy.
    Capello A, Krenning E, Bernard B, Reubi JC, Breeman W, de Jong M.
    Eur J Nucl Med Mol Imaging; 2005 Nov; 32(11):1288-95. PubMed ID: 16021448
    [Abstract] [Full Text] [Related]

  • 18. Differences in biodistribution between 99mTc-depreotide, 111In-DTPA-octreotide, and 177Lu-DOTA-Tyr3-octreotate in a small cell lung cancer animal model.
    Schmitt A, Bernhardt P, Nilsson O, Ahlman H, Kölby L, Forssell-Aronsson E.
    Cancer Biother Radiopharm; 2005 Apr; 20(2):231-6. PubMed ID: 15869461
    [Abstract] [Full Text] [Related]

  • 19. Evaluation of (111)In labeled somatostatin analogs for targeted therapy of somatostatin receptor positive tumors.
    Bernhardt P, Ahlman H, Nilsson O, Benjegård SA, Forssell-Aronsson E.
    Cancer Biother Radiopharm; 2003 Apr; 18(2):249-52. PubMed ID: 12804051
    [No Abstract] [Full Text] [Related]

  • 20. Localization of small-cell lung cancer xenografts with iodine-125-, indium-111-, and rhenium-188-somatostatin analogs.
    Hosono M, Hosono MN, Haberberger T, Zamora PO, Guhlke S, Bender H, Knapp FF, Biersack HJ.
    Jpn J Cancer Res; 1996 Sep; 87(9):995-1000. PubMed ID: 8878464
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.